Introduction c-Myc is a key regulator of cell cycle progression. Enforced c-Myc expression is sucient to promote continuous entry into S phase in the absence of mitogens (Askew et al., 1991; Eilers et al., 1991; Evan et al., 1992) , yet induces apoptosis when cells are deprived of survival factors (Askew et al., 1991; Bissonette et al., 1992; Evan et al., 1992; Harrington et al., 1994) . In addition, ablation of c-Myc arrests cells in the G 1 phase of the cell cycle (reviewed in Amati and Land, 1994; Marcu et al., 1992; . Thus, c-Myc is both necessary and sucient for progression into S phase. Expression of cMyc is tightly regulated by mitogens. c-Myc is induced within 30 to 60 min of growth factor stimulation of most quiescent cells, peaks at 2 to 4 h and thereafter declines to a constant level throughout subsequent phases of the cell cycle (Marcu et al., 1992; Waters et al., 1991) . Conversely, the short half life of c-Myc ensures that c-Myc expression is rapidly downregulated in cells following removal of mitogens (LuÈ scher and Eisenman, 1990) .
c-Myc functions as a transcription factor than can activate or suppress gene expression (Amati et al., 1992; Kretzner et al., 1992; Li et al., 1994) . Speci®c DNA binding of c-Myc is greatly facilitated by its interaction with its obligate partner Max (Blackwood and Eisenman, 1991; Blackwood et al., 1992; Prendergast et al., 1991) , and Max is required for cMyc functions (Amati et al., 1992 (Amati et al., , 1993a Mukherjee et al., 1992; Prendergast et al., 1992) . c-Myc:Max complexes bind to E-box sequences with a central CACGTG core and activate transcription from reporter plasmids containing CACGTG sequences in co-transfection studes (Amati et al., 1992; BelloFernandez et al., 1993; Blackwood and Eisenman, 1991; Kretzner et al., 1992) . More recently, Max has also been demonstrated to associate with the Mad family of proteins (Mad1-4) (Ayer et al., 1992 Hurlin et al., 1995; Zervos et al., 1993) and Mad:Max complexes repress transcription from reporter plasmids containing CACGTG sequences and thus antagonize cMyc activity Ayer et al., , 1995 Schreiber-Agus et al., 1995) .
The rapid induction of c-Myc following mitogenstimulation of quiescent cells suggests that c-Myc regulates gene expression during the early G 1 phase of the cell cycle. Numerous c-Myc target genes have been suggested, including a-prothymosin (Eilers et al., 1991; Gaubatz et al., 1995) , p53 (Hermeking and Eick, 1994; Reisman et al., 1993) , eIF-4E (Rosenwald et al., 1993) , C/EBPa (Li et al., 1994) , ECA 39 (Benvenisty et al., 1993) , cyclin A (Jansen- Durr et al., 1993; Hoang et al., 1994) , cdc25A (Galaktionov et al., 1996 , cad (Miltenberger et al., 1995 , LDH (Tavtigian et al., 1994) , LFA (Inghirami et al., 1990) , PAI-1 (Prendergast and Cole, 1989) and others (Grandori et al., 1996) . However, complications of de®ning c-Myc speci®c targets is that some are dependent upon speci®c cell contexts (e.g. a-prothymosin, p53 and ECA39, refs. Tavtigian et al., 1994; Wagner et al., 1994; Benvenisty et al., 1993) and others may be indirecly activated by the c-Myc's ability to promote continuous cell cycle progression (e.g. cyclin A, p53 and cad). However, expression of the best characterized target of c-Myc, ornithine decarboxylase (ODC) (Askew et al., 1991; Bello-Fernandez et al., 1993; Packham and Cleveland, 1994; PenÄ a et al., 1994; Tavtigian et al., 1994; Tobias et al., 1995; Wagner et al., 1993) , is (like c-Myc) independent of cell cycle phase in growing cells yet modulated by mitogen withdrawal or stimulation (Askew et al., 1991; Bowlin et al., 1986; Van Dalen Wetters et al., 1989) . ODC catalyzes the conversion of ornithine to putrescine, a rate limiting step in the biosynthesis of putrescine and the polyamines spermidine and spermine (Pegg, 1986) . Although the exact physiologic function(s) of putrescine and the polyamines are unclear, in the absence of exogenous sources of polyamines (e.g. by using medium containing dialyzed serum to remove polyamines), ODC activity is essential for cell division as pharmacological inhibition of ODC activity prevents S phase entry (Bowlin et al., 1986; Packham et al., 1996) . Enforced cMyc expression in growth factor deprived cells prevents the normal down-regulation of ODC mRNA levels (Askew et al., 1991; Dean et al., 1987; Packham et al., 1996) , and c-Myc activates ODC promoter-reporter gene fusion constructs in transient co-transfection experiments (Bello-Fernandez et al., 1993; PenÄ a et al., 1994; Tobias et al., 1995; Wagner et al., 1993) . Activation of ODC transcription by c-Myc does not require intermediate protein synthesis (Tavtigian et al., 1994; Wagner et al., 1993) , and is mediated by binding of c-Myc:Max complexes to E-box elements within the ODC gene (Bello-Fernandez et al., 1993) . In the murine ODC gene, c-Myc-responsiveness is mediated by two conserved CACGTG sequences in the ®rst intron of the gene (Bello-Fernandez et al., 1993; Tobias et al., 1995) . Although activation of the human ODC promoter by c-Myc and serum has been reported to be mediated by a single E-box located upstream of the RNA start site (PenÄ a et al., 1994) , this site is not conserved and this region is totally dispensable for activation of the murine ODC promoter by c-Myc (Bello-Fernandez et al., 1993; Tobias et al., 1995) . Finally, ODC is an important eector of c-Myc functions, since pharmacologic inhibition of ODC activity delay apoptosis of IL-3 deprived 32D.3 cells induced by enforced c-Myc expression .
The induction of c-Myc precedes that of ODC when quiescent cells are stimulated with growth factors (Askew et al., 1991) , suggesting that c-Myc contributes to regulation of ODC. Although expression of ODC, like c-Myc, is regulated at many levels, increased transcription is an important component of the response to mitogens Van Dalen Wetters et al., 1989) . However, the control of ODC transcription is complex and in addition to c-Myc, members of several other families of transcription factors have been demonstrated to regulate the transcription of the ODC promoter, including cAMP dependent factors, c-Fos, steroid hormones and IRF-1 (Abrahamsen et al., 1992; Manzella et al., 1994; Moshier et al., 1992; Wrighton and Busslinger, 1993) .
Here we have addressed the issue of whether c-Myc function is speci®cally required in the regulation of mitogen dependent genes such as ODC. Activation of ODC gene expression and promoter activity following IL-3 stimulation of quiescent myeloid cells occurs in two temporal phases. The ®rst involves transient activation of a pre-existing factor and is c-Mycindependent. However, the second phase of induction of the ODC promoter by IL-3 requires c-Myc and cMyc is also necessary for maximal induction of ODC expression. Therefore, the ability of c-Myc to promote continuous cell cycle progression may re¯ect its physiologic role as a regulator that sustains expression of key mitogen dependent genes that are necessary for S phase entry.
Results
The ODC promoter is regulated by IL-3 through conserved c-Myc:Max E-boxes in ODC intron 1
To determine the mechanism of regulation of ODC expression IL-3, we used two murine myeloid progenitor cell lines, FDC-P1.2 and 32D.3. These cells require IL-3 for growth and expression of ODC and c-myc RNAs, and following cytokine deprivation expression of these RNAs is rapidly down-regulated and cells accumulate in a G 0 -like state (Askew et al., 1991; Dean et al., 1987) . Following removal of IL-3, FDC-P1.2 cells remain viable (480%) for up to 40 h (date not shown). By contrast, 32D.3 cells are more susceptible to apoptosis, and cell death is ®rst apparent at 15 h following IL-3 withdrawal (Askew et al., 1991) . Therefore, for practical reasons we focused on FDC-P1.2 cells, although similar experiments were performed in 32D.3 cells.
To determine if the ODC promoter was growth factor dependent and which sequences in the ODC promoter might be required for IL-3 dependent activity, FDC-P1.2 cells were washed thoroughly to remove IL-3, maintained in medium lacking IL-3 for 4 h and then transfected with the ODCDCAT or ODC CAT constructs. These reporter constructs contain exon 1, intron 1 and part of exon 2 of the murine ODC gene fused to the CAT reporter gene and either 264 bp or approximately 2.5 Kbp of sequences upstream of the ODC RNA start site, respectively (Brabant et al., 1988) . Transfected cells were then divided into two¯asks, and either maintained in the continued absence of IL-3 or were supplemented with puri®ed IL-3 (100 U per ml). After 16 h, cells were collected and analysed for CAT activity. FDC-P1.2 cells deprived of IL-3 accumulate in G 1 /G 0 whereas those cells treated with IL-3 were only transiently deprived of IL-3 and are cycling; therefore, this experiment compares ODC promoter activity in asynchronous, proliferating cells with G 0 -arrested, IL-3 deprived cells. Cells transfected with either ODC promoter-reporter construct expressed approximately 15-fold higher CAT activity when maintained in IL-3, relative to cells deprived of cytokine (Figure 1a) . This was not due to non-speci®c activation of transcription or translation, as control constructs were only minimally activated by IL-3. Therefore, the ODC promoter is IL-3 responsive.
Activation of the human ODC promoter by c-Myc or serum has been reported to require a single E-box element located at 7480 upstream of the transcriptional start site (PenÄ a et al., 1994) . By contrast, activation of the murine promoter by c-Myc is mediated by two conserved E-boxes located in ODC intron 1, with no contribution from sequences upstream 7 264 Bello-Fernandez et al., 1993; Tobias et al., 1995) . Since ODC CAT and ODCDCAT reporter plasmids responded equally well to IL-3 (Figure 1a ), sequences upstream of 7264 of the murine promoter do not contribute to IL-3 responsiveness. Therefore, in parallel to examining the eects of IL-3 upon the activity of the ODC CAT and ODCDCAT reporter constructs, we also tested whether the c-Myc-responsive E-box sequences in ODC intron 1 contributed to activation of ODC transcription by IL-3. FDC-P1.2 cells were therefore also transfected with the wild-type construct ODCDCATS 7 or the ODCDCATS 7 5A plasmid in which both E-boxes have been mutated (to CACCTG), and deprived of IL-3 or maintained in IL-3. Similar to ODCDCAT, the wild-type reporter ODCDCATS 7 was eciently activated by IL-3 ( Figure  1a ). However, mutation of both E-boxes (in ODCD-CATS 7 5A) signi®cantly inhibited induction by IL-3 ( Figure 1A ). Similar results were obtained using 32D.3 cells (data not shown).
To determine whether the c-Myc-responsive E-box sequences ODC intron 1 were also sucient to confer IL-3 responsiveness, we tested whether IL-3 could activate expression from a heterologous promoter construct containing the ODC-derived c-Myc:Max Eboxes. Transactivation of heterologous promoter constructs containing two copies of an ODC cMyc:Max E-box by c-Myc is more ecient than with reporter constructs containing a single binding site , and we therefore generated a heterologous promoter construct, (MB2)2.TK.CAT, in which two copies of an oligonucleotide containing the second (3') c-Myc-responsive E-box from ODC intron 1 (MB2, Bello-Fernandez et al., 1993) were cloned upstream of the minimal HSV-1 TK promoter (TK.CAT). This plasmid was eciently induced by IL-3 (Figure 1b ), but at a signi®cantly lower level than the bona®de ODC promoter CAT constructs. This regulation was dependent on the CACGTG sequences, as mutation of both central E-box cores to CACCTG in (MB2.M1)2.TK.CAT completely prevented activation. Therefore, the activity of murine ODC promoter in asynchronously growing cells is dependent upon IL-3, and the intronic c-Myc-responsive E-boxes are both necessary and sucient for this response, although anking sequences may in¯uence the magnitude of induction of transcription.
Mapping of RNA start sites of ODC-CAT fusion transcripts
To con®rm that regulation of transcription of ODC-CAT fusion constructs by IL-3 re¯ected that of the endogenous gene, we analysed ODC-CAT fusion transcripts in FDC-P1.2 cells transiently transfected with the ODCDCATS 7 or ODCDCATS 7 5A plasmids using Northern blotting and RNase protection assays (RPA). Total RNA was ®rst analysed by Northern blotting using probes speci®c for CAT and the coding region of the ODC gene, which hybridizes only to ODC RNA derived from the endogenous ODC gene. One major and two minor CAT-containing RNAs were induced by IL-3 in cells transfected with plasmid ODCDCATS 7 , but not ODCDCATS 7 5A (Figure 2a) . The most abundant of these was of the expected size for the ODC-CAT fusion RNA. By contrast, the endogenous ODC RNA was similarly induced in cells transfected with either plasmid (Figure 2a) .
To compare the structure of ODC and ODC-CAT fusion transcripts we performed RPAs using this total RNA and riboprobes which span the ODC RNA start site (Brabant et al., 1988; Katz and Kahana, 1988) , the ®rst exon and part of the second exon of ODC fused to the 5' portion of the CAT gene (Probe A, Figure 2c ). These assays were performed using RNase T1 only, since RNA duplexes containing the AU-rich sequences in the CAT portion of the fusion RNAs were prone to`breathing' and CAT fusion transcripts could not be detected when we additionally used RNase A. As predicted, endogenous ODC transcripts were induced by IL-3 in cells transfected with either reporter construct (Figure 2b ). The use of only RNase T1 altered mapping of endogenous ODC start sites (Brabant et al., 1988; Katz and Kahana, 1988) . This was due to incomplete digestion of unprotected probe, as the expected protected products were observed when both RNase T1 and A were used (data not shown). We detected ODC-CAT fusion transcripts induced by IL-3 in cells transfected with the wild-type reporter plasmid ODCDCATS 7 , but not the mutant ODCDCATS 7 5A (indicated as ODC Exon1+2-CAT). Importantly, these RNAs initiated at an equivalent (Katz and Kahana, 1988 ) and the CAT portion of each probe as well as relevant restriction sites is shown. Below is indicated the expected protected products of endogenous ODC and ODC-CAT fusion RNAs using each probe c-Myc mediates induction of ODC by IL-3 G Packham and JL Cleveland consistent with protection of RNAs having only ODC exon 2 and the CAT portion of the probe. It is not clear whether these RNAs are due to aberrant splicing or transcription initiation, but they likely correspond to the larger CAT RNAs detected as minor transcripts in the Northern analysis of these RNAs ( Figure 2a ). To con®rm the structure of these ODC-CAT fusion RNAs, we also performed an RPA using a second probe, probe B, which lacked approximately 100 bp of sequence from the CAT portion of probe A ( Figure  2c ). As expected, the protected fragments derived from endogenous ODC RNAs were the same size with either probe, whereas protected fragments from RNAs containing CAT sequences were decreased in size by 100 bp when analysed using probe B (Figure 2b ). Therefore, IL-3 induced transcription from the ODC-CAT fusion plasmids faithfully duplicates the transcription of the endogenous gene, although some minor aberrant RNAs are also generated. Askew et al., 1991; Packham et al., 1996) . Mapping ODC RNA start sites by RPA using probe A (see Figure 2c ) demonstrated identical start sites for ODC RNA isolated from 32D.3 cells growing in IL-3 and from c-Myc overexpressing cells deprived of IL-3 ( Figure 3 , right panels). Therefore, c-Myc promotes transcription of ODC through identical start sites as those utilized by IL-3 signaling.
Induction of ODC by IL-3 has both immediate and delayed components
Induction of c-myc RNA by mitogens is rapid and is resistant to inhibitors of protein synthesis and is therefore typical of an immediate early response gene (Cleveland et al,. 1989; Marcu et al., 1992) . In IL-3 stimulated 32D.3 and FDC-P1.2 myeloid cells, induction of ODC RNA is delayed relative to cmyc RNA, more consistent with a delayed early response (Akew et al., 1991) . However, ODC regulation has also previously been reported to contain an immediate early component Van Dalen Wetters et al., 1989) . To resolve this issue, we analysed the kinetics of induction of c-myc and ODC RNAs in IL-3 stimulated FDC-P1.2 cells, in the presence or absence of cycloheximide to inhibit protein synthesis.
FDC-P1.2 cells were deprived of IL-3 for 20 hours and total RNA was isolated from IL-3 depleted cells, and from these cells at speci®c intervals following the addition of IL-3 and/or cycloheximide. ODC RNA was analysed by Northern blotting (Figure 4a ) and quantitated relative to Cu/ZnSOD RNA (Figure 4b ), whose levels were not appreciably regulated by IL-3 or cycloheximide (Figure 4a ). We analysed c-myc In the right panels the same RNAs were analysed by RPA using probe A (see Figure 2c ). Y indicates yeast RNA as a negative control RNA levels and as expected c-myc was rapidy induced by IL-3 and reached a maximum 1 h post-stimulation (data not shown, see also Dean et al., 1987; Cleveland et al., 1989) . A modest induction of ODC mRNA was also observed within 1 h of IL-3 stimulation, yet levels of ODC transcripts continued to accumulate during the 12 h time course of the experiment. As previously reported in other cells (Van Dalen Wetters et al., 1989) , cycloheximide alone induced modest levels of ODC RNA, and ODC levels were further elevated in cells treated with cycloheximide plus IL-3, relative to cells treated with IL-3 (Figure 4a ). However, after 3 h, cycloheximide prevented the continued accumulation of ODC RNA observed in cells treated with IL-3 alone. The decrease in ODC RNA expression at this time was speci®c, as c-myc RNA remained elevated in cycloheximide plus IL-3 treated cells (data not shown, and see Cleveland et al., 1989) . Therefore, induction of ODC RNA by IL-3 occurs in two phases that are distinguished by their requirement for de novo protein synthesis. The ®rst phase of ODC induction is typical of an immediate early response, albeit with kinetics delayed relative to the rapid induction of c-myc (Askew et al., 1991; Dean et al., 1987) . However, the second phase of ODC induction requires protein synthesis and is therefore typical of a delayed early response. Since regulation of the ODCDLUC reporter construct by IL-3 mimics the temporal regulation of the endogenous ODC gene, as measured by increases in ODC RNA (Figure 4 ) or enzyme activity ( Figure  5b ), sequences within plasmid ODCDLUC (i.e., 7264 to +2020) are sucient to direct the correct kinetic regulation of ODC expression by IL-3. To determine the requirements of the two intronic c-Myc:Max E boxes, we assayed in parallel the eects of IL-3 on the activity of the mutant ODCDLUCS 7 5A reporter. These mutations had virtually no eect on the immediate phase of the induction up to 2 h poststimulation (Figure 5b, top panel) . However, at later times, levels of luciferase activity were greatly diminished in the mutant reporter relative to the wild type ODCDLUC reporter. Activation of luciferase activity by IL-3 in transfected cells was speci®c, as luciferase activity was not induced by IL-3 in cells transfected with the control MDR promoter-reporter plasmid 7250LUC (Scheutz et al., 1995) (data not shown). Therefore, similar to the temporal biphasic regulation of the ODC gene, regulation of the ODC promoter following IL-3 stimulation is also biphasic with respect of c-Myc responsive sequences and these sequences are speci®cally required for the delayed phase of the response.
c-Myc is required for the induction of ODC by IL-3
Since induction of c-Myc by IL-3 correlates with the delayed phase of ODC induction by IL-3 and c-Myc promotes ODC expression via the same transcriptional start sites as IL-3, c-Myc is a good candidate as the mediator of this response. To determine the role of cMyc in the regulation of ODC by IL-3, we used a dominant negative c-Myc protein, In373-Myc (Stone et al., 1987; Dang et al., 1989; Sawyers et al., 1991) , to suppress c-Myc functions. In373-Myc eectively competes with c-Myc for association with Max, and In373-Myc:Max complexes fail to bind DNA; this mutant therefore speci®cally blocks c-Myc funtion by sequestering Max (Katzav et al., 1995; Mukherjee et al., 1992) . FDC-P1.2 cells were co-electroporated with either linearized ODCDLUC or ODCDLUCS 7 5A plasmids, and a plasmid conferring resistance to hygromycin B. Pools of stably transfected cells were selected in hygromycinB and single cell clones were derived. Representative clones were then transfected with the Dex-inducible wild type human c-Myc or In373-Myc pMAM-neo expression plasmids, or with the empty vector pMAM-neo, and doubly resistant cells were selected in the presence of hygromycin B and G418.
To con®rm inducible expression of human c-Myc and In373-Myc in the ODC promoter transfectants, we analysed human c-Myc levels in pools of transfected cells by immunoblot analyses of extracts isolated from cells growing in IL-3 with and without treatment with Dex ( Figure 6 ). Both c-Myc and In373-Myc were overexpressed in the pools of transfected FDC-P1.2/ ODCDLUC and ODCDLUCS 7 5A clones and these Moreover, levels of In373-Myc in these pools were equivalent to c-Myc following treatment with Dex ( Figure 6 ). In 32D.3 myeloid cells (Askew et al., 1991; Packham et al., 1996) and many other cells types (Bissonnette et al., 1992; Eilers et al., 1991; Evan et al., 1992; Harrington et al., 1994) enforced c-Myc expression promotes mitogen-independent cell cycle progression and induces apoptosis when cells are deprived of survival factors. To characterize the biological consequences of enforced c-Myc and In373-Myc in FDC-P1.2 cells transfectants we initially characterized their rates of death following removal of IL-3. As expected, pools of FDC-P1.2 cells overexpressing human c-Myc had accelerated rates of death compared to vector-only control pools (data not shown). By contrast, cells overexpressing In373-Myc had rates of death similar to those of control pools (data not shown), which agrees with the failure of this mutant to induce apoptosis in ®broblast cells .
To determine the eects of c-Myc and In373-Myc on endogenous ODC gene expression and ODC promoter activity, we measured ODC RNA levels (Figure 7a , all data derived from the same Northern blot with identical exposure times) and luciferase activity (Figure 7b ) before and at speci®c intervals after stimulation of IL-3 deprived cells. As expected, IL-3 induced ODC RNA in Neo-vector transfected cells harboring either the ODCDLUC or ODCDLUCS 7 5A reporters ( Figure 7a and data not shown), but ODC promoter activity was maximally induced only in cells containing the wild-type ODCDLUC reporter plasmid (Figure 7b ). Luciferase activity was induced at early As demonstrated in other cell types (Askew et al., 1991; Tavtigian et al., 1994) constitutive expression of wild-type c-Myc in FDC-P1.2 cells was sucient to promote continuous expression of endogenous ODC RNA in the absence of IL-3 (Figure 7a ). Enforced cMyc expression also induced luciferase activity in cells containing ODCDLUC, but not ODCDLUCS 7 5A, in the absence of IL-3 (Figure 7b) . Furthermore, overexpression of c-Myc magni®ed the response of the ODCDLUC reporter, and of the endogenous ODC gene, to ligand (Figure 7) . Expression of the dominant negative c-Myc protein In373-Myc did not appreciably modulate luciferase activity in cells containing either reporter plasmid in the absence of IL-3. However, expression of In373-Myc eectively suppressed the delayed phase of IL-3 mediated induction of luciferase activity in cells containing ODCDLUC (Figure 7b) , and both the early and late phases of induction of the endogenous ODC gene (by greater than 75%, Figure  7a ). By contrast, expression of In373-Myc did not appreciably eect the ®rst phase of induction of the ODC promoter in cells transfected with either ODCDLUC or ODCDLUCS 7 5A. Therefore, dominant negative c-Myc interferes with the induction of the ODC gene by IL-3 and the delayed, but not immediate, phase of activation of its promoter.
The eects of enforced c-Myc and In373-Myc upon regulation of ODC and its promoter could be due to their eects upon the cell cycle. To address this issue, cells were deprived of ligand in the presence of Dex and analysed for their cell cycle distributions by FACS analyses after deprivation of IL-3 for 20 h (Figure 8 ). Ligand starved cells were also stimulated with excess IL-3 (100 U per ml) and harvested at speci®c intervals. As expected, c-Myc overexpressing pools failed to accumulate in G 1 (Figure 8a ) and continued to enter into S phase in the absence of IL-3 (Figure 8b ), whereas In373-Myc overexpressing cells accumulated in G 1 to the same extent as control pools (Figure 8) . Overexpression of In373-Myc only slightly delayed the progression of cells through G 1 and entry into S phase (Figure 8b) , and in asynchronously growing cells overexpression of In373-Myc only slightly inhibits rates of cell growth (data not shown). Therefore, at least for the levels of In373-Myc protein expressed in these pools, the inhibitory eects on In373-Myc upon the induction of ODC and its promoter appear largely independent of its eects upon cell cycle re-entry and progression.
Discussion
We have demonstrated that c-Myc is a major and direct regulator of ODC expression and promoter activity in the response of myeloid cells to IL-3. In (Askew et al., 1991; Packham et al., 1996; Tavtigian et al., 1994) or promoter activity (Bello-Fernandez et al., 1993; Tobias et al., 1995; Wagner et al., 1993) by c-Myc is mediated by two conserved Myc:Max E boxes in ODC intron 1 and ODC is an important mediator of c-Myc functions . Moreover, like cMyc, the regulation of ODC expression is mitogen dependent, but is independent of cell cycle phase. This fact discriminates ODC from several other transcriptional targets ascribed to c-Myc (Hoang et al., 1994; Jansen-Durr et al., 1993; Miltenberger et al., 1995) , which may be indirectly activated due to c-Myc eects at promoting continuous cell cycle progression.
At least two distinct mechanisms mediate induction of ODC and its promoter in response to IL-3. From analyses of exponentially growing cells, and at delayed time points following IL-3 stimulation of quiescent cells, the major regulatory sequences of the ODC promoter are the two intronic c-Myc:Max E boxes, which are necessary for maximal induction of IL-3 and for transactivation by c-Myc (Bello-Fernandez et al., 1993; Wagner et al., 1993; Tobias et al., 1995) . By contrast, during the immediate phase of IL-3 stimulation, induction of ODC is mediated by a distinct pathway, as it is not perturbed by mutation of the ODC E-boxes and activation of the gene occurs in the absence of protein synthesis. Whether this immediateearly activation is mediated by distinct sequences or by a factor which can bind equally to both the wild type and mutant E boxes is not clear. A heterologous luciferase-based reporter harboring two copies of ODC MB2 site upstream of the minimal HSV-1 TK promoter is only activated at relatively late time points by IL-3 (data not shown), suggesting that the early phase is mediated by sequences entirely distinct from the E-boxes.
In general, the regulation of the activity of the ODC promoter by IL-3 mimics the regulation of the endogenous ODC gene. In particular, the immediate versus delayed phase of induction of the ODC promoter by IL-3 correlates well with dierences in the requirement for de novo protein synthesis for the induction of ODC RNA by IL-3. The immediateearly, E-box-independent, pathway correlates with a protein synthesis-independent mechanism of ODC activation and induction of the mutant ODC reporter is not blocked by removing c-Myc functions. By contrast, the delayed phase, which is E-box-dependent, requires protein synthesis for maintenance of ODC expression and this response is blocked by enforced expression of dominant negative c-Myc. Thus, a simple model for the regulation of ODC transcription by IL-3 suggests that immediately following receptor stimulation the activity of a pre-existing factor is altered and this induces ODC gene expression through sequences other than the intronic E boxes. This is temporally followed by a protein synthesis-and cMyc-dependent phase that requires the E boxes, and c-Myc is the primary regulator of ODC in proliferating cells. These results also have broader implications for c-Myc's role as a regulator of transcription. Speci®cally, one of c-Myc's functions may be as a transcriptional regulator that converts a transient, immediate-early, activation event in target genes into the sustained induction of gene expression. Consistent with this concept, c-Myc is able to sustain the expression of mitogen dependent genes such as ODC when cells are deprived of growth factors (Figure 7a and see Askew et al., 1991; Packham et al., 1996) , yet is a relatively poor transactivator of reporter constructs (Kretzner et al., 1992) .
At present the identity of the factor which mediates the immediate-early phase of the response of the ODC promoter to IL-3 is unknown. Although the region of the ODC promoter that is sucient for this response contains several cAMP responsive elements and ODC transcription can be activated by cAMP-dependent pathways (Abrahamsen et al., 1992) , we have not observed any signi®cant eect of mutation of these sites on ODC promoter activity during any phase of the response (data not shown), again demonstrating the speci®city of the ODC E-box response to IL-3. De®nition of sequences required for the immediate phase of the response should lead to identi®cation of the regulatory factor(s). Candidates include members of the STAT family of transcription factors which preexist in quiescent cells and are activated following stimulation of the IL-3 receptor (Ihle, 1995) .
Multiple lines of evidence support the hypothesis that c-Myc functions as a direct and required regulator of ODC transcription and mediates the delayed, protein synthesis-dependent, phase of activation of ODC promoter by IL-3. First, c-Myc is sucient to activate or sustain expression of the endogenous ODC gene (Figure 7a and refs. Askew et al., 1991; Packham et al., 1996; Tavtigian et al., 1994; Wager et al., 1993) , and does so through the same ODC RNA start sites as IL-3. Second, induction of ODC by c-Myc is transcriptional on the basis of nuclear run-on experiments (Tavtigian et al., 1994; Wagner et al., 1993) , is not due to eects of c-Myc upon ODC RNA half-life (data not shown) and does not require intermediate protein synthesis (Tavtigian et al., 1994; Wagner et al., 1993) . Third, c-Myc activates ODC promoter-reporter gene fusion constructs by binding of c-Myc:Max complexes to the two conserved CACGTG sequences in ODC intron 1 (Bello-Fernandez et al., 1993; Tobias et al., 1995; Wagner et al., 1993) and these same sequences are critical for the delayed phase of induction of the ODC promoter in response to IL-3. Fourth, the kinetics of c-Myc induction by IL-3 approximate the kinetics of the delayed phase of the response of ODC to IL-3, which requires protein synthesis. The delayed phase of induction of ODC is therefore consistent with a requirement for de novo synthesis of c-Myc in response to IL-3. Finally, and most compelling, the induction of both the ODC gene and its promoter is suppressed by inducible overexpression of a c-Myc dominant negative protein, In373-Myc (Stone et al., 1987) . In373-Myc functions as a speci®c dominant negative regulator of c-Myc functions by competing with c-Myc for dimerization with Max and forming complexes which cannot bind DNA (Katzav et al., 1995; Mukherjee et al., 1992) . Overexpression of In373-Myc thus ensures that Max is at least partially sequestered into complexes which cannot bind DNA and its speci®city for Max assures that its eects on ODC promoter activity and gene induction are independent of other factors such as USF, TFE3, aand TFEB, which can also bind the canonical site CACGTG (Blackwood and Eisenman, 1991) . Therefore, In373-Myc mediated inhibition of the induction of ODC formally and speci®cally implicates both c-Myc and Max in the induction of ODC by IL-3.
A complicating issue of de®ning c-Myc transcriptional targets has been that many may be indirectly activated through c-Myc's ability to promote continuous cell cycle progression, and these concerns could also apply to c-Myc's regulation of ODC. In particular, overexpression of In373-Myc would be predicted to inhibit cell growth and its eects on ODC promoter activity and gene expression could be attributed to its eects on cell cycle. However, overexpression of In373-Myc in ®broblasts suppresses but does not ablate colony formation (Roussel et al., 1995; Stone et al., 1987) and in the pools of In373-Myc overexpressing myeloid cells which we have isolated, inducible In373-Myc expression has only very modest eects upon cell growth rates (data not shown) and cell cycle re-entry (Figure 8 ). By contrast, In373-Myc had appreciable inhibitory eects on the delayed phase of induction of the ODC promoter and of the induction of the ODC gene by IL-3. Thus, although we haven't strictly eliminated this caveat, its seems likely that c-Myc's regulation of ODC is direct and not secondary to its eects upon cell cycle. In agreement with this concept overexpression of E2F-1 in 32D.3 myeloid cells (Hiebert et al., 1995) , which also promotes continuous entry into S phase in the absence of IL-3, fails to support ODC expression in the absence of IL-3 (Cleveland, unpublished results) .
The ability of In373-Myc overexpressing myeloid cells to re-enter the cell cycle and progress into S phase, in the apparent absence of appreciable levels of ODC suggests, at least on the surface, that ODC activity is not required for S phase entry. However, the products of ODC, putrescine and the polyamines spermidine and spermine, can be recovered by cells from media components, in particular from serum. For example, inhibition of ODC enzyme activity by treatment with speci®c inhibitors (e.g., di¯uoromethylornithine) is only associated with myeloid cell cycle arrest (in G 1 ) in cells carried in medium supplemented with dialyzed serum (and lacking polyamines), and this is rescued by coculture with putrescine (the product of ODC, Packham et al., 1996) . Under these culture conditions, cells overexpressing c-Myc are similarly arrested in G 1 (Packham et al., 1996) . Thus, in this situation ODC is a mitogen regulated c-Myc target necessary for S phase entry. Indeed, in our experiments (Figure 7 and 8) the ability to rescue ODC inhibition by culture in medium containing polyamines (from serum) may contribute to the failure of In373-Myc expression to block cell cycle re-entry.
In addition to positive regulation during mitogenic stimulation, ODC transcription also seems to be actively repressed in the absence of IL-3. Presumably the factor(s) which mediate repression have short half lives, since inhibition of protein synthesis in IL-3 starved cells is sucient to induce ODC RNA expression. Although Max homodimers and/or Mads:Max complexes can repress E-box dependent transcription Lahoz et al., 1994; Schreiber-Agus et al., 1995) , it is not clear that repression of ODC transcription in FDC-P1.2 cells deprived of IL-3 involves these factors. First, a reduction in activity of the reporters is likely independent of the intronic E-boxes, since the activity of the ODCDLUC and ODCDLUCS-5A was comparable in IL-3 deprived cells (Figures 5b and 7b) . Second, compromising the functions of the Myc-Max-Mad network by overexpression of In373-Myc did not appreciably relieve repression of the ODCDLUC reporter following IL-3 deprivation (Figure 7b) . However, transient overexpression of Mxi-1 has been reported to suppress levels of ODC RNA (Wu et al., 1996) and enforced expression of In373-Myc had inhibitory eects on the induction of the endogenous ODC gene which were not re¯ected in its eect on the ODC promoter (Figure 7) . Moreover, others have demonstrated that the ratios of Mad-1:Max to cMyc:Max complexes increase upon dierentiation and since ODC is down regulated during dierentiation, it may be a target for repression by Mads factors during this process. Therefore, it is possible that the regulation of ODC transcription will also serve as a model for genes which are actively repressed by the Mad family of transcription factors.
The ability of In373-Myc to eectively abrogate activation of ODC expression by IL-3, independent of appreciable eects on cell cycle, established that c-Myc is a key regulator of genes such as ODC which are mitogen dependent. This contrasts ODC to other transcriptional targets ascribed to c-Myc such as cyclin E, cyclin A, cad and cdc25 (Galaktionov et al., 1996; Hoang et al., 1994; Jansen-Durr et al., 1993; Miltenberger et al., 1995) , whose expression is also cell cycle regulated, despite continuous amounts of c-Myc. Whether these targets are indirectly activated by cMyc's eects on cell cycle, or that the ability of c-Myc to regulate a subset of targets is cell cycle dependent remains to be determined. Cell cycle regulation of cMyc transactivation function has been described (Colman and Ostrowski, 1996; Seth et al., 1993) . Alternatively, the activity of c-Myc antagonists may be cell cycle dependent. Using inducible expression systems in synchronized myeloid cells we are testing this hypothesis. However, it is clear that other c-Myc dependent genes such as ODC are critical components in the response of quiescent cells to mitogens and our results suggest that c-Myc functions as an integrator which sustains the transcription of ODC in response to signaling pathways which induce cell cycle re-entry.
Materials and methods

Cell Culture
The FDC-P1.2 and 32D.3 cell lines (Askew et al., 1991; Dean et al., 1987) are IL-3 dependent diploid murine myeloid progenitor cells and were maintained in medium supplemented with IL-3 (20 U per ml) as previously described (Askew et al., 1991; Dean et al., 1987) . Cells were made quiescent by withdrawal of IL-3 for 20 h (FDCc-Myc mediates induction of ODC by IL-3 G Packham and JL Cleveland P1.2) or 15 h (32D.3) and then stimulated with IL-3 (100 U per ml). The myc.2 cells were generated by electroporating 32D.3 cells with the murine c-myc-neo retrovirus expression construct fpGV-myc (Dean et al., 1987) and have been described previously (Askew et al., 1991) .
To determine the eects of enforced expression of c-Myc and dominant negative In373-Myc (Stone et al., 1987) on FDC-P1.2 cell cycle progression and ODC promoter activity, we generated stable transfectants. Pools of FDC-P1.2 cells stably transfected with the ODCDLUC (wild-type promoter) or ODCDLUCS 7 5A (mutant promoter) reporter constructs were generated as previously described (Hiebert et al., 1995) by co-transfection with the pRMM plasmid, which expresses the hygromycin phosphotransferase gene from the pGK promoter (kindly provided by Celeste Simon, University of Chicago) and selection in IL-3 medium containing hygromycin B (0.8 mg per ml). Single cell clones were generated by limiting dilution. The LUC reporter and pRMM plasmids were linearized using XmnI and KpnI, respectively, before transfection. The resultant FDC-P1.2/ODCDLUC and FDC-P1.2/ODCDLUCS 7 5A cells were then electroporated with NdeI-linearized, dexamethasone (Dex)-inducible, pMAM-neo, pMAM-neo human c-Myc or pMAM-neo In373-Myc expression plasmids and pools of transfected cells selected in IL-3 medium containing hygromycin (0.8 mg per ml) and G418 (0.4 mg per ml).
To address the eects of enforced c-Myc and In373-Myc expression on cell cycle progression and ODC promoter activity, FDC-P1.2-derived clones were set at 0.3610 6 cells per ml on two consecutive days. On the third day, cells were pre-treated with Dex (1.5 mM) for 16 h, washed twice in medium lacking IL-3 and resuspended at 0.3610 6 cells per ml in medium lacking IL-3, but containing 1.5 mM Dex. Cells were subsequently stimulated with IL-3 (100 U per ml). Cell cycle distibution was determined using a FACscan (BectonDickinson) as previously described (Askew et al., 1991; Hiebert et al., 1995) .
Transcient tranfections of ODC promoter-reporter constructs were performed using DEAE dextran as previously described (Suzow and Friedman, 1993) . Cycloheximide (Sigma) was used to block protein synthesis. Treatment of FDC-P1.2 cells with cycloheximide (25 mg per ml) inhibited incorporation of 35 S-methionine into trichloroacetic acidprecipitable material by 96% within 15 min (data not shown).
ODC promoter-reporter constructs
The ODC CAT and ODCDCAT reporter constructs were a kind gift of Philip Cono (University of California, San Francisco) (Brabant et al., 1988) . Previously, we used the plasmid ODCDCATDS5A which has a site-directed mutation (CACGTG to CACCTG) introduced into each of the E-boxes in ODC intron1, as well as an additional 123 bp SmaI deletion (Bello-Fernandez et al., 1993) . Here, we generated the wild type control plasmid ODCDCATS 7 and the mutant reporter plasmid ODCDCATS 7 5A which contains the same E-box mutations, in which the SmaI deletion was repaired. First, ODCDCAT was digested with SmaI (which removed ODC sequences 7134 to +398 relative to the ODC CAP site, Katz and Kahana, 1988) and the large vector fragment isolated. ODC sequences from +276 to +396 were replaced into this vector fragment in the appropriate orientation using synthetic nucleotides, thereby destroying the SmaI site at +398 and leaving a unique SmaI site available for subsequent cloning. SmaI fragments spanning ODC sequences 7134 to +275 were prepared from the wild type plasmid ODCDCAT and the double E-box mutant plasmid ODCDCATDS 7 5A and cloned into the unique SmaI site in the correct orientation to give ODCDCATS 7 and ODCDCATS 7 5A, respectively. The constructs were con®rmed by sequencing.
The heterologous promoter constructs (MB2)2.TK.CAT and (MB2.M1)2.TK.CAT were generated by cloning two copies of the double stranded oligonucleotide MB2 (AGG GGA CAC GTG TCG CGA) or MB2.M1 (AGG GGA CAC CTG TCG CGA), respectively, upstream of the minimal herpes simplex virus type I (HSV-1) thymidine kinase (TK) promoter pBLCAT2 , here called TK.CAT. The oligonucleotides were cloned into the BamHI site of TK.CAT that had been blunt ended. The constructs were con®rmed by sequencing.
The generate luciferase reporter constructs we ®rst engineered polyadenylation signals 3' to the luciferase open reading frame. Two copies of a double stranded oligonucleotide (TAT GTG ACG TGA CGT GAC CAA TAA AGG) were cloned into the StuI site of plasmid pGEM-luc (Promega) which contains the luciferase gene from P. pyralis, to give pGEM-lucpoly(A). pGEM-lucpoly(A) was then digested with HindIII and XhoI, and the smaller fragment which contains the luciferase gene and polyadenylation signals isolated and bluntended. To generate ODCDLUC and ODCDLUCS 7 5A, the CAT sequences were removed from plasmids ODCDCAT and ODCDCATS
7
5A by digestion with SalI and PfmlI and replaced with the luciferase-poly (A) fragment derived above. The 7250LUC control reporter construct was a kind gift of John Scheutz (St Jude Children's Research Hospital) and contains the 5' region (up to 7250 bp) of the human multidrug resistance gene promoter cloned upstream of the luciferase gene (Scheutz et al., 1995) .
Riboprobes and RNase protection assays (RPA)
To generate riboprobes to analyse endogenous ODC RNAs and exogenous ODC-CAT fusion RNAs by RPA, the unique BglI site in pGEM-2 (Promega) was destroyed by digestion with BglI, blunt-ending and re-ligation to give pGEM-2.6.1. ODCDCAT was digested with PvuI (which cuts at ODC-79), blunt-ended with T4 polymerase and then digested with EcoRI which cuts at ODC+784 and also within the CAT gene. The smaller PvuI ± EcoRI ODC and EcoRI ± EcoRI ODC-CAT fusion fragments were isolated, and the PvuI-EcoRI fragment cloned into pGEM-2.6.1 digested with SalI and blunt-ended, with the PvuI site closest to the SP6 promoter. This ligation regenerates the SalI and EcoRI sites, and the SalI site was then destoyed by digestion, blunt-ending and re-ligation. Next, the EcoRI ± EcoRI ODC-CAT fusion fragment was cloned into the unique EcoRI site in the appropriate orientation to give pGEM-ODCDCAT. Finally, plasmid pGEM-ODCDCAT was digested with BglI (which cuts at the 3' end of ODC exon 1) and SalI (which cuts at the ODC-CAT fusion boundary in exon 2) and the intervening sequences replaced with a synthetic oligonucleotide which generates the exon 1-exon 2 spliced form of the gene and eliminates intron 1, to give pRiboODC. pRiboODC was cut using EcoRI and the larger fragment isolated and re-ligated to give pRiboODCderiv. pRiboODC and pRiboODCderiv were linearized with HindIII and riboprobes generated using SP6 to give probes A and B, respectively.
RPA were performed using the RPA kit II (Ambion) according to the manufacturer's instructions. Brie¯y, total RNA (20 mg) or poly(A) + RNA (4 mg) was hybridized overnight at 428C with an excess of riboprobe. An equivalent amount of yeast RNA was used as a negative control. Single stranded RNA was digested with RNAse A plus T1 (for endogenous ODC transcripts) or RNAse T1 alone (for ODC-CAT fusion transcripts) and protected fragments analysed by denaturing gel eletrophoresis.
Western blotting
Murine c-Myc and Max, and human c-Myc and In373-Myc expression was detected by immunoblotting. Due to c-Myc mediates induction of ODC by IL-3 G Packham and JL Cleveland the instability of murine c-Myc in myeloid cells, we measured protein levels in direct cell lysates. Cell (5610 6 ) were collected by centrifugation and resuspended in boiling SDS sample buer. Samples were sonicated to shear genomic DNA, clari®ed by centrifugation and then boiled for 5 min. Soluble proteins were resolved by SDS ± PAGE and electrophoretically transferred to nitrocellulose. Non-speci®c binding sites were blocked by incubation with 5% (w/v) non-fat milk in phosphate buered saline. Murine c-Myc was detected using the c-Mycspeci®c antibody 06-340 (Upstate Biotechnology Inc.) as described by the manufacturer's instructions and human cMyc proteins were detected using the human c-Mycspeci®c antibody 9E10 (a kind gift of Dr P Dias, St Jude Children's Research Hospital). Murine Max was detected using a rabbit antisera we have generated against a GST fusion protein which contains the C-terminal 92 aminoacid residues of human Max. Bound immunocomplexes were detected by enhanced chemiluminescence according to the manufacturer's instructions (Amersham).
ODC, CAT and luciferase assays
ODC and CAT enzyme were performed as previously described (Bello-Fernandez et al., 1993; Packham and Cleveland, 1994) . Luciferase activity was measured using The Luciferase Assay System (Promega) as described by the manufacturer and a OpticompI luminometer (MGM Instrument, Inc). To eliminate variations from transfection eciencies, myeloid cells transiently transfected with ODC reporter plasmids were transfected in the absence of IL-3 for 4 h, washed and then split into medium with or without IL-3. All transfection experiments were repeated numerous times and respresentative data are shown. Protein determinations were made using Bradford assay with bovine serum albumin as a standard.
Northern blotting
Isolation of total and poly(A) + RNA, Northern blotting and the c-myc and ODC probes have been described previously (Askew et al., 1991; Cleveland et al., 1989) . The Cu/Zn superoxide dismutase (Cu/ZnSOD) probe was a 600 bp EcoRI fragment of the rat cDNA (Ho and Crapo, 1987) . The CAT probe used to detect ODC-CAT fusion RNA was a 800 bp BamHI ± HindIII fragment of the CAT gene. The GAPDH probe was a 1.0 Kbp murine cDNA (provided by AT Look, St Jude Children's Research Hospital). Quantitation of Northern hybridization signals was done by phosphoimager (Molecular Dynamics, Inc) analysis of radioactive hybridizing RNA. All RNA blot data shown were derived from RNAs analysed on the same Northern blot with identical exposure times.
